Wall Street mostly rises after encouraging inflation data despite Lilly's drag
Drops for Lilly and Big Tech weigh on Wall Street, even as most stocks rise
 · 4dSoutheast Missourian
Stock market today: Drops for Lilly and Big Tech weigh on Wall Street, even as most stocks rise
New inflation report gives most stocks a boost; Capital One sued by watchdog over savings accounts
Stocks got a boost from a report showing inflation at the U.S. wholesale level wasn’t as high last month as expected. Lilly weighed on the market after saying growth for some of its blockbuster drug products isn't as strong as it expected.
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
 · 1dWHDH
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
 · 1dBioPharma Dive
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
5 Things to Know Before the Stock Market Opens
U.S. stock futures point higher ahead of closely watched CPI report, JPMorgan Chase stock rises on better-than-expected results, and economists expect annual inflation to have risen in December. Here's what investors need to know today.
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens
The S&P 500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's consumer price report.
Novo Nordisk stock prices drop after Biden lists Ozempic for price negotiations
Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs for mandatory price negotiations.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
24/7 Wall St3d
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and currently trading at $747.20. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,
CPI Slows, Bank Earnings Show Growth And Rising Expectations For 2025
Inflation data this week has come in below forecasts. Earnings season is off to a solid start. Is this the medicine the market needs?
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
California is not one of those states. Newsom in October rejected a $35 monthly insulin copay cap. In his veto message, he cited the state’s $100 million investment in insulin production as an example of his administration’s efforts to reduce costs without a price cap.
Jim Cramer on Eli Lilly and Company (LLY): ‘There’s Been Some Mistakes’
We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks.
Kelly Evans: Stocks surge on CPI and strong banks
Today is like a little taste of what the year could be like if everything goes just right. Inflation is cooler, bond yields have chilled out, bank earnings are coming in strong, and stocks are up 1.7%.